KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Income from Continuing Operations (2019 - 2026)

GoodRx Holdings' Income from Continuing Operations history spans 7 years, with the latest figure at 5425000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 19.51% to 5425000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 30439000.0, a 85.72% increase, with the full-year FY2025 number at 30439000.0, up 85.72% from a year prior.
  • Income from Continuing Operations hit 5425000.0 in Q4 2025 for GoodRx Holdings, up from 1119000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for GDRX hit a ceiling of 58786000.0 in Q2 2023 and a floor of 41734000.0 in Q3 2022.
  • Historically, Income from Continuing Operations has averaged 1006050.0 across 5 years, with a median of 1393500.0 in 2021.
  • The widest YoY moves for Income from Continuing Operations: up 4254.49% in 2023, down 1211.82% in 2023.
  • Tracing GDRX's Income from Continuing Operations over 5 years: stood at 39914000.0 in 2021, then soared by 95.06% to 1972000.0 in 2022, then crashed by 1211.82% to 25869000.0 in 2023, then skyrocketed by 126.05% to 6740000.0 in 2024, then fell by 19.51% to 5425000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for GDRX at 5425000.0 in Q4 2025, 1119000.0 in Q3 2025, and 12843000.0 in Q2 2025.